Radiology Doctors in Hibbing, MN Accepting Medicare

10 Radiology doctors found. Showing 1 - 10

Frank J Suslavich, M.D. Radiology - Body Imaging Medicare: Accepting Medicare Assignments Practice Location: 750 E 34th St, Hibbing, MN 55746 Phone: 218-262-4881    Fax: 218-362-6699

Michael T Semotuk, M.D Radiology - Body Imaging Medicare: Accepting Medicare Assignments Practice Location: 750 E 34th St, Hibbing, MN 55746 Phone: 218-262-4881    Fax: 218-362-6699

Dr. Daniel Scott Vechell, M.D. Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 1200 E 25th St, Hibbing, MN 55746 Phone: 218-312-3005    Fax: 218-312-3003

Dr. Gerald Thomas Mccullough, M.D. Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 750 E 34th St, Hibbing, MN 55746 Phone: 218-262-4881    Fax: 218-362-6699

Anne T Goldschmidt, M.D. Radiology - Body Imaging Medicare: Accepting Medicare Assignments Practice Location: 750 E 34th St, Hibbing, MN 55746 Phone: 218-262-4881    Fax: 218-362-6699

William Schwartau, M.D. Radiology - Diagnostic Radiology Medicare: Not Enrolled in Medicare Practice Location: 750 E 34th St, Hibbing, MN 55746 Phone: 218-362-6683    Fax: 218-362-6684

Dr. Christopher Mark Reilly, M.D. Radiology - Body Imaging Medicare: Accepting Medicare Assignments Practice Location: 750 E 34th St, Hibbing, MN 55746 Phone: 218-262-4881    Fax: 218-362-6699

Quinn H Carmichael, M.D. Radiology - Body Imaging Medicare: Accepting Medicare Assignments Practice Location: 750 E 34th St, Hibbing, MN 55746 Phone: 218-262-4881    Fax: 218-362-6699

Daniel Lee Courneya, M.D. Radiology - Body Imaging Medicare: Accepting Medicare Assignments Practice Location: 1200 E 25th St, Hibbing, MN 55746 Phone: 218-312-3005    Fax: 218-312-3003

Dr. Paul Allen Lindholm, M.D. Radiology - Radiation Oncology Medicare: Accepting Medicare Assignments Practice Location: 750 E 34th St, Hibbing, MN 55746 Phone: 218-262-4881    Fax: 218-362-6989

News Archive

Sorrento Therapeutics to acquire San Diego-based Concortis Biosystems

Sorrento Therapeutics, Inc. announced today the entry into a definitive agreement to acquire San Diego-based Concortis Biosystems, Corp. in a deal that provides Sorrento with a comprehensive technology platform for generation of antibody drug conjugates (ADC). Under the terms of the agreement dated November 11, 2013, subject to satisfaction of certain closing conditions, upon closing, Sorrento will issue an aggregate of 1,331,978 shares of its common stock to the Concortis shareholders.

Increase in pneumococcal infections not covered by childhood vaccine

Alaskan native children are experiencing increased rates of serious infections caused by strains of pneumococcal bacteria that are not covered by the current childhood pneumococcal vaccine, indicating the importance of ongoing surveillance of vaccine effectiveness, according to a study in the current issue of JAMA.

Air conditioning coil reduces over all sickness by 20%

Air conditioning coil reduces over all sickness by 20%, reduces respiratory symptoms by 40% and has resulted in a 99% reduction of microbial and endotoxin concentrations on irradiated surfaces within the ventilation system.

Sonora Medical Systems sold to Medical Imaging Holdings for $8 million

Misonix, Inc., a developer of minimally invasive ultrasonic medical device technology, which in Europe is used for the ablation of tumors and worldwide for other acute health conditions, announced today that substantially all of the assets of its subsidiary, Acoustic Marketing Research, Inc., DBA Sonora Medical Systems, were sold to Medical Imaging Holdings, Inc., for $8 million in cash.

Added benefit of ipilimumab in advanced melanoma not proven for non-pretreated patients

The German Institute for Quality and Efficiency in Health Care already assessed the added benefit of ipilimumab in advanced melanoma in 2012. A considerable added benefit was found for patients who had already received previous treatment. In the new dossier compiled by the drug manufacturer, the drug was now compared with the appropriate comparator therapy dacarbazine specified by the Federal Joint Committee (G-BA) also for non-pretreated patients.

Read more Medical News

› Verified 7 days ago